Breaks Categories: News

ThursdayMay 16, 2024 2:45 pm

NetworkNewsBreaks – Shib Inu Named Title Sponsor for Canada’s Largest Web3 Events, Offers Free Tickets to ShibArmy

Shiba Inu (“SHIB”) will be a title sponsor of Canada’s largest Web3 Events: Blockchain Futurist Conference, ETHToronto and ETHWomen. This will be the second year Shiba Inu has been a title sponsor. The three events will take place Aug. 13–14, 2024, in Toronto. Shiba Inu reported a significant response to its first-ever sponsorship of last year’s futurist conference; the event provided an ideal opportunity to bring the SHIB Army together. This year is expected to be similar, with Shytoshi Kusama, the lead developer of the Shiba Inu team, presenting virtually at the conference. To support the SHIB community, free tickets…

Continue Reading

ThursdayMay 16, 2024 2:34 pm

NetworkNewsBreaks – Armlogi Holding Corp. (NASDAQ: BTOC) Announces Public Offering Pricing

Armlogi Holding (NASDAQ: BTOC), a U.S.-based warehousing and logistics service provider that offers a comprehensive package of supply-chain solutions related to warehouse management and order fulfillment, has released the pricing of its initial public offering. The offering is comprised of 1,600,000 shares of common stock at $5 per share, resulting in gross proceeds of $8 million for the company, before the deduction of underwriting discounts and offering expenses. According to the announcement, Armlogi Holding also granted a 45-day option to underwriters to purchase up to 240,000 additional shares of common stock to cover any overallotments. EF Hutton LLC is acting…

Continue Reading

ThursdayMay 16, 2024 2:18 pm

NetworkNewsBreaks – SuperCom Ltd. (NASDAQ: SPCB) Announces Additional $1.8 Million Contract with Long-Standing Government Customer

SuperCom Ltd. (NASDAQ: SPCB), a global provider of secure solutions for the e-Government, IoT, and cybersecurity sectors, today announced it had secured a new, additional contract with a long-standing government customer. According to the announcement, the contract, valued at $1.8 million, continues a successful partnership that has been in place for over a decade. The contract is expected to start by end of May 2024 and to be fulfilled within 5 months. “We are pleased to continue our partnership with a government customer who has trusted our solutions for over a decade. This contract not only signifies their satisfaction with…

Continue Reading

ThursdayMay 16, 2024 2:00 pm

NetworkNewsBreaks – 4th Annual Psychedelic Therapeutics and Drug Development Conference to Bridge Gaps in Research and Development of Therapeutic Psychedelics

Arrowhead Sci-Tech Conferences and Events today announced the 4th Annual Psychedelic Therapeutics and Drug Development Conference, the flagship event for research and therapeutics development in the psychedelics space. The event will be held May 23-24, 2024, at the iconic Revere Hotel Boston Common in Boston, MA. The two-day event is expected to attract the world’s leading researchers and thought leaders in academia, industry, the non-profit sector, and government that aim to bridge gaps in the research and development (“R&D”) sphere related to therapeutic psychedelics. The conference will focus on the R&D of psychedelics for various health conditions with considerable unmet…

Continue Reading

ThursdayMay 16, 2024 1:56 pm

NetworkNewsBreaks – Sow Good Inc. (NASDAQ: SOWG) Closes Overallotment Option in $13.8M Public Offering

Sow Good (NASDAQ: SOWG), a trailblazer in the freeze dried candy and treat industry, recently announced that the underwriters of its completed public offering of common stock had purchased 180,000 shares of its common stock. The underwriters made the purchase upon full exercise of their option to purchase additional shares of common stock to cover overallotments at the initial offering price of $10.00 per unit. Including proceeds from the sale of additional shares, the offering yielded approximately $13.8 million in gross proceeds before deductions. Roth Capital Partners acted as sole book-running manager for the offering, while Craig-Hallum acted as the…

Continue Reading

ThursdayMay 16, 2024 1:54 pm

NetworkNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Releases Q1 2024 Financial, Business Report

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, is reporting its financial and business results for the first quarter 2024, the period ended March 31, 2024. A highlight of the report was that enrollment is nearly completed in a potentially pivotal GBM study evaluating Berubicin with topline data expected in the first half of 2025. In addition, financial results showed a net loss for the quarter of approximately $3.5 million, down from an estimated $4.9 million net loss for the comparable period…

Continue Reading

ThursdayMay 16, 2024 1:46 pm

NetworkNewsBreaks – SuperCom Ltd. (NASDAQ: SPCB) Achieves Record Profit, 400% YoY EBITDA Growth for Q1 2024

SuperCom (NASDAQ: SPCB), a global provider of secured solutions for the e-government, IoT and cybersecurity sectors, has announced results for the three months ended March 31, 2024. Among the highlights, the company reported an 8% increase in revenue to $6.9 million from $6.4 million and 139% increase in gross profit to $3.8 million from $1.6 million compared to the first quarter of 2023. “We are pleased to report a strong start to 2024, marked by significant financial and operational achievements. This quarter, we’ve continued to see revenue growth YoY and a dramatic improvement in our profitability metrics leading to an…

Continue Reading

ThursdayMay 16, 2024 1:16 pm

NetworkNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Names Seasoned Business Leader to Board of Directors

Nutriband (NASDAQ: NTRB), a developer of transdermal pharmaceutical solutions, has announced a new member of its board of directors. According to the announcement, Sergei Glinka, a seasoned and highly respected business executive, will serve on the board. An Estonian citizen, Glinka has served in several executive and board roles positions in large European companies, including Automecanica Skb Property Srl., GST Investments OU and TG Biochemicals Ltd. Glinka’s expertise will support and facilitate new licensing and networking opportunities for Nutriband throughout Europe as the company works to expand its AVERSA(TM) technology, which is patented in 45 countries. The announcement noted that…

Continue Reading

ThursdayMay 16, 2024 1:02 pm

NetworkNewsBreaks – Tartisan Nickel Corp. (CSE: TN) (OTCQB: TTSRF) (FSE: 8TA) Acquires Additional Contiguous Claims at Kenbridge Nickel Project, Reports Start of 2024 Baseline Study

Tartisan Nickel (CSE: TN) (OTCQB: TTSRF) (FSE: 8TA), a Canadian-based company specializing in mineral exploration and development, is announcing the acquisition of additional contiguous claims at the Kenbridge Nickel Project, Northwestern Ontario. Following the acquisition, the total property now consists of 93 contiguous patents, 153 single cell mining claims and 4 Mining Licenses, covering a total of 4,273 ha. According to the announcement, the patents and staked cells are owned 100% by Tartisan Nickel through wholly owned subsidiaries. The company also announced that Aspen Biological Ltd. staff have commenced the 2024 baseline study fieldwork, which includes completing the baseline aquatic…

Continue Reading

ThursdayMay 16, 2024 1:02 pm

NetworkNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Releases FY 2023 Financial Results, Provides Business Update

Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company focused on the development of inflammation and immunology (“I&I”) biological products and on providing contract development and manufacturing organization (“CDMO”) services through its Scinai Bioservices business unit, is reporting its full-year financial results for 2023 along with a company update. Highlights of the report included news that, in the first four months of 2024, the company has received CDMO work orders valued at approximately $500,000, with current guidance for this year of approximately $1.25 million in expected revenues. The report also noted that the company is “aggressively advancing” its NanoAb preclinical development, with promising results obtained in a…

Continue Reading